Published in Vopr Virusol on July 26, 2011
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl (1999) 1.87
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Biosynthesis and role of filoviral glycoproteins. J Gen Virol (2001) 1.84
Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81
Inhibition of glycosylation of the influenza virus hemagglutinin. J Virol (1974) 1.81
Marburg and Ebola viruses. Adv Virus Res (1996) 1.81
Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol (2000) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73
Release of viral glycoproteins during Ebola virus infection. Virology (1998) 1.73
Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. EMBO J (1982) 1.67
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol (1991) 1.65
Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional 1H n.m.r. and methylation analysis. EMBO J (1985) 1.64
The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology (1998) 1.62
Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. Virology (1995) 1.62
Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology (1995) 1.60
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol (2001) 1.59
Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J (2000) 1.59
Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes. J Exp Med (1980) 1.58
Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virol (1993) 1.58
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest (1993) 1.57
Coronavirus glycoprotein E1, a new type of viral glycoprotein. J Mol Biol (1981) 1.55
Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses. J Gen Virol (1992) 1.53
Carbohydrate structure of Marburg virus glycoprotein. Glycobiology (1992) 1.48
Cotranslational and posttranslational processing of viral glycoproteins. Curr Top Microbiol Immunol (1980) 1.47
Plasma membrane lipids and parainfluenza virus assembly. Virology (1970) 1.44
Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology (1994) 1.44
Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J Virol (1990) 1.43
Proteolytic processing of Marburg virus glycoprotein. Virology (2000) 1.43
Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J Biol Chem (1995) 1.43
Coronaviridae. Intervirology (1983) 1.42
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J Virol (1994) 1.41
Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology (1987) 1.40
Chemical composition of the parainfluenza virus SV5. Virology (1969) 1.39
Human influenza virus hemagglutinin with high sensitivity to proteolytic activation. J Virol (1991) 1.38
Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology (1999) 1.37
Termini of all mRNA species of Marburg virus: sequence and secondary structure. Virology (1996) 1.36
The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. J Virol (1997) 1.35
The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology (1990) 1.34
Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars. J Virol (1977) 1.33
The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. J Gen Virol (1988) 1.33
The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology (1992) 1.32
Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187. EMBO J (1984) 1.32
A comparison of immune cytolysis and virus-induced fusion of sensitive and resistant cell types. Proc Soc Exp Biol Med (1969) 1.31
The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Res (1984) 1.31
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31
Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology (1992) 1.30
Influenza viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care Med (1995) 1.28
Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line. J Biol Chem (1995) 1.27